A, Herpes simplex virus type 2 (HSV-2) detection rate by quantitative polymerase chain reaction by study day during the observational period and valacyclovir suppression. The number of days with swabs collected is noted above each bar. B, Bacterial vaginosis positivity (Nugent score >7) rate during the observational period and valacyclovir suppression phase.